The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Systemic Therapy for Colorectal Cancer
Abstract
Colorectal cancer is one of the most commonly diagnosed malignant diseases, with an estimated 1,023,000 new cases and 529,000 deaths worldwide each year. This review considers recently developed cytotoxic chemotherapies and biologic agents that are effective against colorectal cancer and assesses their use as treatments for metastatic disease and as components of adjuvant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Meta-Analysis Group In Cancer (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.252 · Cited by 441
Research works printed but not linked: 96
- 10.3322/canjclin.55.1.10 · DOI · Paper page
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0. Lyon, France: IARC Press, 2004.
- 10.1056/NEJM199404213301608 · DOI · Paper page
- 10.1016/S0140-6736(00)02034-1 · DOI · Paper page
- 10.1016/S0305-7372(02)00037-3 · DOI
- 10.1002/path.1700350303 · DOI · Paper page
- Greene FL, Balch CM, Fleming ID, et al., eds. AJCC cancer staging handbook. 6th ed. New York: Springer, 2002. · DOI · Paper page
- 10.1136/bmj.306.6880.752 · DOI · Paper page
- Smyth JF, 1995, Ann Oncol, 6, 948, 10.1093/oxfordjournals.annonc.a059365 · DOI
- 10.1016/S0140-6736(94)90750-1 · DOI · Paper page
- 2000, Cochrane Database Syst Rev, 2, CD001545
- Sobrero A, 2000, Semin Oncol, 27, 72
- Zhang ZG, 1992, Semin Oncol, 19, 10
- 10.1200/JCO.2004.03.104 · DOI · Paper page
- Lokich JJ, 1989, J Clin Oncol, 7, 425, 10.1200/JCO.1989.7.4.425 · DOI · Paper page
- de Gramont A, 1997, J Clin Oncol, 15, 808, 10.1200/JCO.1997.15.2.808 · DOI · Paper page
- Weh HJ, 1994, Ann Oncol, 5, 233, 10.1093/oxfordjournals.annonc.a058799 · DOI
- 10.1002/(SICI)1097-0142(19960715)78:2<300::AID-CNCR17>3.0.CO;2-# · doi:10.1002/(sici)1097-0142(19960715)78:2<300::aid-cncr17>3.0.co;2-#
- 10.1002/(SICI)1097-0142(19960715)78:2<294::AID-CNCR16>3.0.CO;2-R · doi:10.1002/(sici)1097-0142(19960715)78:2<294::aid-cncr16>3.0.co;2-r
- 10.1200/JCO.2003.11.122 · DOI · Paper page
- 1998, J Clin Oncol, 16, 301, 10.1200/JCO.1998.16.1.301 · DOI · Paper page
- 10.1002/1097-0142(197504)35:4<1031::AID-CNCR2820350403>3.0.CO;2-N · doi:10.1002/1097-0142(197504)35:4<1031::aid-cncr2820350403>3.0.co;2-n
- Pentheroudakis G, 2002, Anticancer Res, 22, 3589
- 10.1016/S0959-8049(98)00226-3 · DOI
- Sulkes A, 1998, J Clin Oncol, 16, 3461, 10.1200/JCO.1998.16.10.3461 · doi:10.1200/jco.1998.16.10.3461
- 10.1016/S0959-8049(98)00211-1 · DOI · Paper page
- Van Cutsem E, 2001, J Clin Oncol, 19, 4097, 10.1200/JCO.2001.19.21.4097 · DOI · Paper page
- Hoff PM, 2001, J Clin Oncol, 19, 2282, 10.1200/JCO.2001.19.8.2282 · DOI · Paper page
- Mayer RJ, 2001, J Clin Oncol, 19, 4093, 10.1200/JCO.2001.19.21.4093 · DOI
- 10.1200/JCO.2002.10.129 · DOI · Paper page
- 10.1200/JCO.2002.04.123 · DOI · Paper page
- Ward S, 2003, Health Technol Assess, 7, 1, 10.3310/hta7320 · DOI · Paper page
- 10.1001/jama.259.24.3571 · doi:10.1001/jama.259.24.3571 · Paper page
- Moertel CG, 1995, Ann Intern Med, 122, 321, 10.7326/0003-4819-122-5-199503010-00001 · DOI · Paper page
- Haller DG, 1993, Adv Exp Med Biol, 339, 51, 10.1007/978-1-4615-2488-5_6 · doi:10.1007/978-1-4615-2488-5_6
- Haller DG, 1998, Proc Am Soc Clin Oncol, 17, 982
- Wolmark N, 1999, J Clin Oncol, 17, 3553, 10.1200/JCO.1999.17.11.3553 · DOI · Paper page
- 10.1200/JCO.2004.09.059 · DOI · Paper page
- Wolmark N, 2004, J Clin Oncol, 22, 3508, 10.1200/jco.2004.22.14_suppl.3508 · DOI
- 10.1056/NEJMoa010957 · DOI · Paper page
- Mamounas E, 1999, J Clin Oncol, 17, 1349, 10.1200/JCO.1999.17.5.1349 · DOI · Paper page
- Moertel CG, 1995, J Clin Oncol, 13, 2936, 10.1200/JCO.1995.13.12.2936 · DOI · Paper page
- 1999, J Clin Oncol, 17, 1356, 10.1200/JCO.1999.17.5.1356 · DOI · Paper page
- 10.1200/JCO.2004.05.063 · DOI · Paper page
- 10.1002/(SICI)1097-0142(19980901)83:5<882::AID-CNCR12>3.0.CO;2-R · doi:10.1002/(sici)1097-0142(19980901)83:5<882::aid-cncr12>3.0.co;2-r
- 10.1385/IJGC:30:3:147 · DOI
- 10.1200/JCO.20.6.1499 · DOI · Paper page
- 10.1097/00000658-199812000-00006 · DOI · Paper page
- 10.1056/NEJM199912303412702 · DOI · Paper page
- 10.1007/s002800051077 · doi:10.1007/s002800051077
- 10.1067/mcp.2002.129502 · DOI
- Mathijssen RH, 2001, Clin Cancer Res, 7, 2182
- 10.1038/sj.tpj.6500072 · DOI · Paper page
- 10.1023/A:1008438109725 · DOI · Paper page
- 10.1200/JCO.2004.07.173 · DOI · Paper page
- 10.1016/S0140-6736(98)03085-2 · DOI · Paper page
- 10.1056/NEJM200009283431302 · DOI · Paper page
- Rothenberg ML, 2001, J Clin Oncol, 19, 3801, 10.1200/JCO.2001.19.18.3801 · DOI · Paper page
- Goldberg RM, 2004, J Clin Oncol, 22, 3621, 10.1200/jco.2004.22.14_suppl.3621 · doi:10.1200/jco.2004.22.14_suppl.3621
- Hwang JJ, 2003, Oncology (Huntingt), 17, 37
- Raymond E, 1998, Semin Oncol, 25, 4
- 10.1016/S0006-2952(97)81490-6 · DOI · Paper page
- 10.1097/00001813-199710000-00009 · DOI · Paper page
- 10.1200/JCO.2003.11.126 · DOI · Paper page
- Raymond E, 2002, Mol Cancer Ther, 1, 227
- 10.1016/S0093-7754(03)00399-3 · DOI · Paper page
- de Gramont A, 2000, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938 · DOI · Paper page
- Becouarn Y, 1998, J Clin Oncol, 16, 2739, 10.1200/JCO.1998.16.8.2739 · DOI · Paper page
- 10.1023/A:1008200825886 · DOI · Paper page
- 10.1016/0959-8049(93)90073-O · DOI · Paper page
- Machover D, 1996, Ann Oncol, 7, 95, 10.1093/oxfordjournals.annonc.a010489 · DOI · Paper page
- Giacchetti S, 2000, J Clin Oncol, 18, 136, 10.1200/JCO.2000.18.1.136 · DOI · Paper page
- Grothey A, Deschler B, Kroening H, et al. Phase III study of bolus 5-fluorouracil (5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/ FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC). In: Program and abstracts of the American Society of Clinical Oncology 38th Annual Meeting, Orlando, Fla., May 18–21, 2002. abstract. · DOI
- 10.1200/JCO.2004.09.046 · DOI · Paper page
- Grothey A, 2003, Prog Proc Am Soc Clin Oncol, 22, 255
- 10.1200/JCO.2004.11.037 · DOI · Paper page
- 10.1200/JCO.2004.10.182 · DOI · Paper page
- 10.1056/NEJMoa032709 · DOI · Paper page
- 10.1634/theoncologist.7-suppl_4-2 · doi:10.1634/theoncologist.7-suppl_4-2 · Paper page
- 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2 · DOI · Paper page
- 10.1002/jso.2930510304 · DOI
- 10.1016/S0889-8588(02)00055-2 · DOI
- Saltz L, 2001, Prog Proc Am Soc Clin Oncol, 20, 3a
- 10.1200/JCO.2004.10.182 · DOI · Paper page
- 10.1200/JCO.2003.10.066 · DOI · Paper page
- Kabbinavar F, 2004, J Clin Oncol, 22, 3516, 10.1200/jco.2004.22.14_suppl.3516 · doi:10.1200/jco.2004.22.14_suppl.3516
- Saltz L, 2003, Prog Proc Am Soc Clin Oncol, 22, 204a
- Berlin JD, 2002, Oncology (Huntingt), 16, 13
- 10.1007/s11912-001-0008-5 · doi:10.1007/s11912-001-0008-5
- Kornmann M, 2003, Clin Cancer Res, 9, 4116
- 10.1016/S1091-255X(02)00018-5 · doi:10.1016/s1091-255x(02)00018-5
- 10.1200/JCO.2003.07.039 · DOI
- Berglund A, 2002, Anticancer Res, 22, 3653
- Aschele C, 2000, Clin Cancer Res, 6, 4797
- 10.2165/00003088-200039050-00001 · DOI
- 10.1038/sj.bjc.6601487 · doi:10.1038/sj.bjc.6601487
Cited by
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
Mayer, R. J., Van Cutsem, E., Falcone, A., Yoshino, T., Garcia-Carbonero, R., Mizunuma, N., Yamazaki, K., Shimada, Y., Tabernero, J., Komatsu, Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414325 · Cited by 1,431
Self-citationDetection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080
Self-citation
Metadata
- Authors
- Meyerhardt, J. A., & Mayer, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-02-03
- Volume
- 352
- Issue
- 5
- Pages
- 476-487
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2069305509
- Cited by
- 1,043
- References
- 8
- FWCI
- 30.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic Therapy for Colorectal Cancer. https://app.cochat.ai/papers/10.1056/nejmra040958
- The paper
- Meyerhardt, J. A., & Mayer, R. J. (2005). Systemic Therapy for Colorectal Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmra040958
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.